Home › Funds › Hikari Power Ltd › CRVS

Hikari Power Ltd position in CRVS

CORVUS PHARMACEUTICALS INC · Health Care

Hikari Power Ltd reported holding 49,959 shares of CRVS (CORVUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$576K, representing 0.13% of its reported portfolio and ranking #24 among its reported holdings. Hikari Power Ltd has disclosed CRVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)49.96K sh
Reported value held$576.00K
Portfolio Weight0.13%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hikari Power Ltd's CRVS position evolved

Hikari Power Ltd first disclosed a stake in CRVS in Q3 2023 at 49,959 shares (US$73K). The position peaked in Q2 2026 at 49,959 shares, worth US$746K. Across 13 filings, Hikari Power Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 49,959 shares valued at US$576K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 49.96K $73.00K New
Q4 2023 49.96K $88.00K Hold
Q1 2024 49.96K $89.00K Hold
Q2 2024 49.96K $91.00K Hold
Q3 2024 49.96K $264.00K Hold
Q4 2024 49.96K $267.00K Hold
Q1 2025 49.96K $159.00K Hold
Q2 2025 49.96K $200.00K Hold
Q3 2025 49.96K $368.00K Hold
Q4 2025 49.96K $385.00K Hold
Q1 2026 49.96K $731.00K Hold
Q2 2026 49.96K $746.00K Hold
Q3 2026 49.96K $576.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRVS and 13F data

CRVS (CORVUS PHARMACEUTICALS INC) is a Health Care company. 67 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), PERCEPTIVE ADVISORS LLC (US$39.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRVS

All CRVS fund holders →

FAQ

How long has Hikari Power Ltd held CRVS?

Hikari Power Ltd has disclosed CRVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hikari Power Ltd's current position in CRVS?

As of Q3 2026, Hikari Power Ltd holds 49.96K shares of CRVS (CORVUS PHARMACEUTICALS INC), valued at $576.00K, representing 0.13% of its reported portfolio and ranking #24.

Has Hikari Power Ltd been buying or selling CRVS?

In the latest 13F filing (Q3 2026), Hikari Power Ltd held unchanged its position in CRVS. The position peaked in Q2 2026 at 49.96K shares.

Which other funds hold CRVS?

Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, PERCEPTIVE ADVISORS LLC, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.